T2D and Osteoporosis Risk: A Mendelian Randomisation Study

Area of Science:

• Endocrinology and Metabolic Diseases
• Bone Health and Osteoporosis Research
• Genetic Epidemiology

Background:

• Type-II Diabetes (T2D) is a global health concern with increasing prevalence.
• Osteoporosis (OP) is characterized by reduced bone density and increased fracture risk.
• The relationship between T2D and OP requires further investigation to establish causality.

Purpose of the Study:

• To investigate the potential causal effect of Type-II Diabetes (T2D) on the risk of developing Osteoporosis (OP).
• To utilize Mendelian randomization (MR) as a robust method for causal inference in this association.
• To analyze large-scale genome-wide association study (GWAS) data for genetic variants related to T2D and OP.

Main Methods:

• A two-sample Mendelian randomization (MR) study design was employed.
• Genome-wide association study (GWAS) data from East Asian populations were utilized, including 433,540 variants for T2D and 212,453 for OP.
• Genetic variants served as instrumental variables, analyzed using inverse variance weighted (IVW), MR-Egger regression, and weighted median estimator (WME) methods.

Main Results:

• Primary MR analysis (IVW) indicated a significant causal association between T2D and OP (OR = 1.0934, p = 0.0007).
• Secondary analyses (MR-Egger and WME) corroborated the causal link, showing T2D increases OP risk (MR-Egger: OR = 1.1142, p = 0.0004; WME: OR = 1.1422, p = 0.0004).
• Sensitivity analyses confirmed the accuracy and robustness of the findings.

Conclusions:

• A significant causal relationship exists between Type-II Diabetes and Osteoporosis.
• The findings demonstrate that T2D is a causal factor that elevates the risk of developing Osteoporosis.
• This study provides strong evidence supporting T2D as a risk factor for OP, informing clinical management and prevention strategies.